Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Carbenicillin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.77 |
| ▸ | RECQL | P46063 | 4/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.77 |
| ▸ | HPGD | P15428 | 3/20 | 0.77 |
| ▸ | POLB | P06746 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | TEK | Q02763 | 1/20 | 0.77 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | RARB | P10826 | 1/20 | 0.64 |
| ▸ | RARG | P13631 | 1/20 | 0.64 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.64 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.64 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbenicillin SCHEMBL11310979 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL11310973 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL13662704 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL320405 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL10520792 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL11604897 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL8402462 | 1.00 | PTGS1 (0.77) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL193749 | 0.99 | PTGS1 (0.76) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL28801787 | 0.99 | PTGS1 (0.76) | PTGS1KDM4ERECQLTDP1HPGD | |
| Carbenicillin SCHEMBL7341688 | 0.99 | PTGS1 (0.76) | PTGS1KDM4ERECQLTDP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 66335 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144896-A1 | MODIFIED CPG DINUCLEOTIDES FOR RECOMBINANT VIRAL VECTOR PRODUCTION | SIREN BIOTECHNOLOGY, INC. (US) | 2026-05-28 | — | — | US | claimed |
| CN-122080185-A | Targeting carp herpesvirus II type nano antibody and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| CN-122071712-A | Beta-lactam antibiotic whole-cell biosensor, construction method and application | 中国科学院天津工业生物技术研究所 | 2026-05-22 | — | — | CN | claimed |
| US-20260137809-A1 | GENE THERAPY VECTORS FOR TREATMENT OF CANCER | SIREN BIOTECHNOLOGY INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026104587-A1 | CYCLIC BORONIC ACID ESTERS USEFUL AS ADJUVANTS IN THE TREATMENT OF BACTERIAL INFECTIONS | ADJUTEC PHARMA AS (NO) | 2026-05-21 | — | — | WO | claimed |
| WO-2026104986-A1 | NEW MOLECULES AND THEIR USE IN THE TREATMENT OF PATHOLOGIES RELATED TO OXIDATIVE STRESS | FIDIA FARMACEUTICI S.P.A. (IT) | 2026-05-21 | — | — | WO | claimed |
| EP-4743580-A1 | EFFICIENT TRANSGENE-FREE GENOME EDITING IN PLANTS IN THE T0 GENERATION BASED ON A CO-EDITING STRATEGY | University of Florida Research Foundation, Incorporated (US) | 2026-05-20 | — | — | EP | claimed |
| CN-115215923-B | Macrocyclic broad-spectrum antibiotics | 豪夫迈·罗氏有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-121534221-B | Chitosan fiber antibacterial gel and preparation method thereof | 武汉纺织大学 | 2026-05-15 | — | — | CN | claimed |
| EP-0008917-A1 | Penam-3-carboxylic acid 1,1-dioxides, process for their preparation and pharmaceutical compositions | PFIZER INC. (US) | 1980-03-19 | — | — | EP | claimed |
| EP-0007717-A1 | Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1980-02-06 | — | — | EP | claimed |
| EP-0007690-A1 | Process for the production of a polysaccharide | TATE & LYLE PATENT HOLDINGS LIMITED (BM) | 1980-02-06 | — | — | EP | claimed |
| EP-0004925-A1 | Synergistic mixtures of antibiotics and process for their production | CIBA-GEIGY AG (CH) | 1979-10-31 | — | — | EP | claimed |
| EP-0005014-A1 | Clavulanic acid derivatives, preparation and compositions | BEECHAM GROUP PLC (GB) | 1979-10-31 | — | — | EP | claimed |
| EP-0003618-A1 | Antibacterial composition and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-08-22 | — | — | EP | claimed |
| US-4145429-A | VEGETALBE OIL, CLAY, ANTIBIOTIC | BEECHAM GROUP LIMITED (GB) | 1979-03-20 | — | — | US | claimed |
| US-4143134-A | BACTERICIDES, ANTIBIOTIC POTENTIATORS | HOFFMANN-LA ROCHE INC. (US) | 1979-03-06 | — | — | US | claimed |
| US-4134972-A | OLIGOPEPTIDES | HOFFMANN-LA ROCHE INC. (US) | 1979-01-16 | — | — | US | claimed |
| US-4127649-A | PEPTIDES | HOFFMANN-LA ROCHE INC. (US) | 1978-11-28 | — | — | US | claimed |